Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Boehringer Ingelheim Pharmaceuticals |
---|---|
Information provided by: | Boehringer Ingelheim Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00319813 |
A Cross sectional observational Quality Assurance Project in General Practice to COPD Diagnosis and Treatment
Condition | Intervention | Phase |
---|---|---|
Pulmonary Disease, Chronic Obstructive |
Behavioral: Education |
Phase IV |
Study Type: | Observational |
Official Title: | General Practice Quality Assurance Project. COPD Diagnosis and Treatment |
Estimated Enrollment: | 8000 |
Estimated Study Completion Date: | September 2007 |
Ages Eligible for Study: | 35 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 205.376 |
Study First Received: | April 20, 2006 |
Last Updated: | April 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00319813 History of Changes |
Health Authority: | Denmark: Danish Dataprotection Agency |
Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases |
Respiration Disorders Chronic Disease Pulmonary Disease, Chronic Obstructive |
Disease Attributes Lung Diseases, Obstructive Pathologic Processes Respiratory Tract Diseases |
Lung Diseases Respiration Disorders Chronic Disease Pulmonary Disease, Chronic Obstructive |